Tonic interferon restricts pathogenic IL-17-driven inflammatory disease via balancing the microbiome

  1. Isabelle J Marie  Is a corresponding author
  2. Lara Brambilla
  3. Doua Azzouz
  4. Ze Chen
  5. Gisele V Baracho
  6. Azlann Arnett
  7. Haiyan S Li
  8. Weiguo Liu
  9. Lluisa Cimmino
  10. Pratip Chattopadhyay
  11. Gregg Silverman
  12. Stephanie S Watowich
  13. Bernard Khor
  14. David Levy  Is a corresponding author
  1. NYU School of Medicine, United States
  2. BD Life Sciences, United States
  3. Benaroya Research Institute at Virginia Mason, United States
  4. MD Anderson, United States
  5. University of Miami Miller School of Medicine, United States

Abstract

Maintenance of immune homeostasis involves a synergistic relationship between the host and the microbiome. Canonical interferon (IFN) signaling controls responses to acute microbial infection, through engagement of the STAT1 transcription factor. However, the contribution of tonic levels of IFN to immune homeostasis in absence of acute infection remains largely unexplored. We report that STAT1 KO mice spontaneously developed an inflammatory disease marked by myeloid hyperplasia and splenic accumulation of hematopoietic stem cells. Moreover, these animals developed inflammatory bowel disease. Profiling gut bacteria revealed a profound dysbiosis in absence of tonic IFN signaling, which triggered expansion of TH17 cells and loss of splenic Treg cells. Reduction of bacterial load by antibiotic treatment averted the TH17 bias, and blocking IL17 signaling prevented myeloid expansion and splenic stem cell accumulation. Thus, tonic IFNs regulate gut microbial ecology, which is crucial for maintaining physiologic immune homeostasis and preventing inflammation.

Data availability

Sequencing data related to microbiome analysis have been deposited in Dryad at http://dx.doi.org/10.5061/dryad.b5mkkwhcvSource data files for other figures are provided with the manuscript.

The following data sets were generated

Article and author information

Author details

  1. Isabelle J Marie

    Pathology, NYU School of Medicine, New York, United States
    For correspondence
    Isabelle.Marie@nyulangone.org
    Competing interests
    No competing interests declared.
  2. Lara Brambilla

    Pathology, NYU School of Medicine, New York, United States
    Competing interests
    No competing interests declared.
  3. Doua Azzouz

    Pathology and Medicine, NYU School of Medicine, New York, United States
    Competing interests
    No competing interests declared.
  4. Ze Chen

    Medicine, NYU School of Medicine, New York, United States
    Competing interests
    No competing interests declared.
  5. Gisele V Baracho

    Immunology, BD Life Sciences, La Jolla, United States
    Competing interests
    Gisele V Baracho, Gisele Baracho is affiliated with BD Life Sciences. The author has no financial interests to declare.
  6. Azlann Arnett

    Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, United States
    Competing interests
    No competing interests declared.
  7. Haiyan S Li

    Immunology, MD Anderson, Houston, United States
    Competing interests
    No competing interests declared.
  8. Weiguo Liu

    Pathology, NYU School of Medicine, New York, United States
    Competing interests
    No competing interests declared.
  9. Lluisa Cimmino

    Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, United States
    Competing interests
    No competing interests declared.
  10. Pratip Chattopadhyay

    Medicine, NYU School of Medicine, New York, United States
    Competing interests
    No competing interests declared.
  11. Gregg Silverman

    Pathology and Medicine, NYU School of Medicine, New York, United States
    Competing interests
    No competing interests declared.
  12. Stephanie S Watowich

    Immunology, MD Anderson, Houston, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1969-659X
  13. Bernard Khor

    Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4689-5092
  14. David Levy

    Pathology and Microbiology, NYU School of Medicine, New York, United States
    For correspondence
    david.levy@med.nyu.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7320-7788

Funding

National Institutes of Health (A!28900)

  • Isabelle J Marie
  • David Levy

National Institutes of Health (AI133822)

  • Stephanie S Watowich

National Institutes of Health (AR070591)

  • Gregg Silverman

National Institutes of Health (CA016087)

  • Pratip Chattopadhyay

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animals used in these experiments were maintained in a single dedicated room of a specific pathogen-free vivarium at NYU Grossman School of Medicine. All work with experimental animals was in accordance with protocols approved by the NYU Langone Health Institutional Animal Care and Use Committee (IACUC ID: IA16-01579).

Copyright

© 2021, Marie et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,829
    views
  • 272
    downloads
  • 25
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Isabelle J Marie
  2. Lara Brambilla
  3. Doua Azzouz
  4. Ze Chen
  5. Gisele V Baracho
  6. Azlann Arnett
  7. Haiyan S Li
  8. Weiguo Liu
  9. Lluisa Cimmino
  10. Pratip Chattopadhyay
  11. Gregg Silverman
  12. Stephanie S Watowich
  13. Bernard Khor
  14. David Levy
(2021)
Tonic interferon restricts pathogenic IL-17-driven inflammatory disease via balancing the microbiome
eLife 10:e68371.
https://doi.org/10.7554/eLife.68371

Share this article

https://doi.org/10.7554/eLife.68371

Further reading

    1. Immunology and Inflammation
    Denise M Monack
    Insight

    Macrophages control intracellular pathogens like Salmonella by using two caspase enzymes at different times during infection.

    1. Immunology and Inflammation
    2. Medicine
    Haiyi Fei, Xiaowen Lu ... Lingling Jiang
    Research Article

    Preeclampsia (PE), a major cause of maternal and perinatal mortality with highly heterogeneous causes and symptoms, is usually complicated by gestational diabetes mellitus (GDM). However, a comprehensive understanding of the immune microenvironment in the placenta of PE and the differences between PE and GDM is still lacking. In this study, cytometry by time of flight indicated that the frequencies of memory-like Th17 cells (CD45RACCR7+IL-17A+CD4+), memory-like CD8+ T cells (CD38+CXCR3CCR7+HeliosCD127CD8+) and pro-inflam Macs (CD206CD163CD38midCD107alowCD86midHLA-DRmidCD14+) were increased, while the frequencies of anti-inflam Macs (CD206+CD163CD86midCD33+HLA-DR+CD14+) and granulocyte myeloid-derived suppressor cells (gMDSCs, CD11b+CD15hiHLA-DRlow) were decreased in the placenta of PE compared with that of normal pregnancy (NP), but not in that of GDM or GDM&PE. The pro-inflam Macs were positively correlated with memory-like Th17 cells and memory-like CD8+ T cells but negatively correlated with gMDSCs. Single-cell RNA sequencing revealed that transferring the F4/80+CD206 pro-inflam Macs with a Folr2+Ccl7+Ccl8+C1qa+C1qb+C1qc+ phenotype from the uterus of PE mice to normal pregnant mice induced the production of memory-like IL-17a+Rora+Il1r1+TNF+Cxcr6+S100a4+CD44+ Th17 cells via IGF1–IGF1R, which contributed to the development and recurrence of PE. Pro-inflam Macs also induced the production of memory-like CD8+ T cells but inhibited the production of Ly6g+S100a8+S100a9+Retnlg+Wfdc21+ gMDSCs at the maternal–fetal interface, leading to PE-like symptoms in mice. In conclusion, this study revealed the PE-specific immune cell network, which was regulated by pro-inflam Macs, providing new ideas about the pathogenesis of PE.